慢性阻塞性肺疾病患者吞咽障碍评估工具的研究进展

doi:10.3969/j.issn.1000-8535.2023.06.019

广州医药 ›› 2023, Vol. 54 ›› Issue (6): 106-111.DOI: 10.3969/j.issn.1000-8535.2023.06.019

• 综述 • 上一篇

慢性阻塞性肺疾病患者吞咽障碍评估工具的研究进展

陈喻萍¹, 卢茜², 杨磊³, 曾丽娟⁴

1 汕头大学公共卫生学院（汕头市 515063）;
2 深圳市龙岗区疾病预防控制中心（深圳市 518172）;
3 广州医科大学公共卫生学院（广州市 511436）;
4 深圳市龙岗区人民医院护理部（深圳市 518172）

收稿日期:2023-03-08 出版日期:2023-06-20 发布日期:2023-07-27
通讯作者: 卢茜,E-mail：982988368@qq.com
基金资助:
国家自然科学基金资助项目（82073628）

Recent progress of assessment tools for COPD patients with dysphagia

CHEN Yuping, LU Qian, YANG Lei, ZENG Lijuan

1 School of Public Health,Shantou University,Shantou 515063,China;
2 Shenzhen Center for Disease Control and Prevention,Shenzhen 518172,China;
3 School of Public Health,Guangzhou Medical University,Guangzhou 511436,China;
4 Nursing Department,Longgang District People's hospital of Shenzhen,Shenzhen 518172,China

Received:2023-03-08 Online:2023-06-20 Published:2023-07-27

摘要/Abstract

摘要： 吞咽障碍是慢性阻塞性肺疾病（COPD）的常见并发症之一,并且是COPD急性加重的危险因素之一,对患者预后造成不良影响。对COPD患者吞咽障碍的发生及严重程度进行准确的评估,是进行科学管理的首要前提。本文对COPD吞咽障碍评估工具的基本特点、应用现状及发展现状进行综述,为临床医务人员选择评估工具提供借鉴。

关键词: 慢性阻塞性肺疾病, 吞咽障碍, 评估工具, 研究进展

Abstract: Dysphagia is one of the common complications of chronic obstructive pulmonary disease（COPD）,and is one of the risk factors of acute exacerbation of COPD,which has adverse effects on the prognosis of patients．Accurate assessment of the occurrence and severity of dysphagia in COPD patients is the first step for scientific management．In this paper,the basic characteristics,application status and development status of assessment tools for COPD patients with dysphagia are reviewed,which can provide reference for the selection of assessment tools for clinical medical staff．

Key words: chronic obstructive pulmonary disease（COPD）, dysphagia, assessment tool, dysphagia

陈喻萍, 卢茜, 杨磊, 曾丽娟. 慢性阻塞性肺疾病患者吞咽障碍评估工具的研究进展[J]. 广州医药, 2023, 54(6): 106-111.

CHEN Yuping, LU Qian, YANG Lei, ZENG Lijuan. Recent progress of assessment tools for COPD patients with dysphagia[J]. Guangzhou Medical Journal, 2023, 54(6): 106-111.

参考文献

[1] 慢性阻塞性肺疾病急性加重抗感染治疗中国专家共识编写组.慢性阻塞性肺疾病急性加重抗感染治疗中国专家共识[J].国际呼吸杂志,2019,39(17):1281-1296.
[2] GONZALEZ LINDH M,JANSON C,BLOM JOHANSSON M,et al.Swallowing dysfunction in patients hospitalised due to a COPD exacerbation[J].ERJ Open Res,2021,7(2):00173-2021.
[3] 刘妮,郑则广,李有霞,等.洼田饮水试验和简单2步吞咽激发试验评估慢性阻塞性肺疾病急性加重期患者误吸的应用价值[J].中国实用内科杂志,2019,39(10):904-908.
[4] 吕孟菊,柳俊杰,李雪琳.吞咽障碍患者饮食管理方案的构建[J].中华护理杂志,2022,57(12):1427-1434.
[5] 黄继云,郑元.颈椎前路手术后病人吞咽困难评估工具研究进展[J].护理研究,2021,35(8):1452-1456.
[6] EPIU I,GANDEVIA S C,BOSWELL-RUYS C L,et al.Tongue strength and swallowing dynamics in chronic obstructive pulmonary disease[J].ERJ Open Res,2021,7(3):00192-2021.
[7] CVEJIC L,BARDIN P G.Swallow and Aspiration in Chronic Obstructive Pulmonary Disease[J].Am J Respir Crit Care Med,2018,198(9):1122-1129.
[8] HASEGAWA K,SATO S,TANIMURA K,et al.Gastroesophageal reflux symptoms and nasal symptoms affect the severity of bronchitis symptoms in patients with chronic obstructive pulmonary disease[J].Respir Investig,2018,56(3):230-237.
[9] 杨啸燕,颜丽娜,饶高峰,等.医护治一体化康复管理模式在脑卒中患者肺康复中的应用[J].中华物理医学与康复杂志,2020,42(12):1120-1123.
[10] TERAMOTO S,MATSUSE T,FUKUCHI Y,et al.Simple two-step swallowing provocation test for elderly patients with aspiration pneumonia[J].Lancet,1999,353(9160):1243.
[11] 郑晓娜,陈秋华,邵庭芳,等.9种吞咽障碍筛查量表准确性的网状Meta分析[J].中华护理杂志,2019,54(10):1561-1566.
[12] YOSHIMATSU Y,TOBINO K,SUEYASU T,et al.Repetitive saliva swallowing test and water swallowing test may identify a COPD phenotype at high risk of exacerbation[J].Clin Respir J,2019,13(5):321-327.
[13] OHTA K,MURATA K,TAKAHASHI T,et al.Evaluation of swallowing function by two screening tests in primary COPD[J].Eur Respir J,2009,34(1):280-281.
[14] 汤玉蓉,彭巧妮,廖小雯,等.洼田饮水试验联合容积黏度吞咽测试在呼吸内科老年吞咽障碍病人饮食护理中的应用[J].全科护理,2021,19(34):4843-4847.
[15] YAMAMICHI N,SHIMAMOTO T,TAKAHASHI Y,et al.Trends in proton pump inhibitor use,reflux esophagitis,and various upper gastrointestinal symptoms from 2010 to 2019 in Japan[J].PLoS One,2022,17(6):e270252.
[16] SHIRAI T,MIKAMO M,TSUCHIYA T,et al.Real-world effect of gastroesophageal reflux disease on cough-related quality of life and disease status in asthma and COPD[J].Allergol Int,2015,64(1):79-83.
[17] RENGARAJAN A,POMARAT M,ZERBIB F,et al.Overlap of functional heartburn and reflux hypersensitivity with proven gastroesophageal reflux disease[J].Neurogastroenterol Motil,2021,33(6):e14056.
[18] CHEN G,LIU W,LIAO W,et al.An epidemiological survey of gastroesophageal reflux disease at the digestive endoscopy center in Guangzhou[J].Eur Arch Otorhinolaryngol,2021,278(12):4901-4908.
[19] RENGARAJAN A,POMARAT M,ZERBIB F,et al.Overlap of functional heartburn and reflux hypersensitivity with proven gastroesophageal reflux disease[J].Neurogastroenterol Motil,2021,33(6):e14056.
[20] BELAFSKY P C,MOUADEB D A,REES C J,et al.Validity and reliability of the Eating Assessment Tool(EAT-10)[J].Ann Otol Rhinol Laryngol,2008,117(12):919-924.
[21] REGAN J,LAWSON S,de AGUIAR V.The Eating Assessment Tool-10 Predicts Aspiration in Adults with Stable Chronic Obstructive Pulmonary Disease[J].Dysphagia,2017,32(5):714-720.
[22] 窦祖林. 吞咽障碍的规范化评估与治疗中值得注意的几个问题[J].中国康复医学杂志,2020,35(3):257-259.
[23] LANGMORE S E.History of fiberoptic endoscopic evaluation of swallowing for evaluation and management of pharyngeal dysphagia:changes over the years[J].Dysphagia,2017,32(1):27-38.
[24] 中国吞咽障碍康复评估与治疗专家共识组.中国吞咽障碍评估与治疗专家共识(2017年版)第一部分评估篇[J].中华物理医学与康复杂志,2017,39(12):881-892.
[25] BOROWSKY DA ROSA F,SCHUCH L H,PASQUALOTO A S,et al.Endoscopic evaluation of pharyngeal and laryngeal sensation in patients with chronic obstructive pulmonary disease(COPD):A cross‐sectional study[J].Clinl Otolaryngolo,2021,46(3):570-576.
[26] 庄任,方罡,贺颖超,等.表面肌电图技术在脑卒中后吞咽障碍评估中的应用[J].中国临床研究,2019,32(4):493-496.

慢性阻塞性肺疾病患者吞咽障碍评估工具的研究进展

Recent progress of assessment tools for COPD patients with dysphagia

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	吴瑕, 葛红庭. 乙酰半胱氨酸泡腾片联合布地格福气雾剂治疗慢性阻塞性肺疾病疗效及对患者肺功能的影响[J]. 广州医药, 2023, 54(6): 83-87.
[2]	夏婉飞, 黄国华, 古辉, 李雪平, 陈少立, 刘兆男. 噻托溴铵/奥达特罗治疗 C、D 组慢性阻塞性肺疾病稳定期患者的效果[J]. 广州医药, 2023, 54(4): 100-103.
[3]	李峰, 伍颖欣. 比较不同判读标准对COPD合并OSA的诊断及其特点的影响[J]. 广州医药, 2022, 53(6): 14-17.
[4]	蒋新颖, 张悦. 小剂量肾上腺素联合布地奈德雾化吸入在慢性阻塞性肺疾病并发低氧血症患者抢救中的应用价值[J]. 广州医药, 2022, 53(4): 22-25.
[5]	谢健, 邓淑妍, 李学莹, 屈桂妮, 彭晓青. 穿心莲内酯对慢阻肺疾病急性加重期患者的影响[J]. 广州医药, 2022, 53(1): 6-11.
[6]	张林洋, 朱玲玲, 朱国华. 中医药治疗前列腺癌研究进展[J]. 广州医药, 2021, 52(5): 135-138.
[7]	卢心鹏, 廖东江, 罗钰龙, 潘俊辉, 陈鸿生, 王峰. iTRAQ联合质谱技术筛选COPD大鼠肺组织差异表达蛋白[J]. 广州医药, 2020, 51(6): 6-10.
[8]	李晓岩, 陈豫钦, 莫泽珣, 何桦, 张歆, 唐万娜, 谭锦文. 能倍乐对合并前列腺肥大的慢性阻塞性肺疾病急性加重的影响[J]. 广州医药, 2020, 51(3): 73-76.
[9]	罗秋平, 曾笑寒, 田应平, 梁培干, 林观康, 陈蓓蓓. 120例COPD稳定期患者用药情况调查分析[J]. 广州医药, 2019, 50(2): 82-84.
[10]	曾映雪. 全程介入护理对慢性阻塞性肺疾病和哮喘患者管理的治疗效果观察[J]. 广州医药, 2018, 49(6): 121-123.
[11]	郑翠环, 李婷, 张少珍, 魏彩红, 黄明生. 护理干预在慢性阻塞性肺疾病患者中的效果[J]. 广州医药, 2018, 49(4): 47-50.
[12]	马程远, 关键, 张中宏, 梁文晋, 任侠, 王耀林. HHIP基因rs13118928、rs13141461与新疆蒙古族慢性阻塞性肺疾病易感性的相关性研究[J]. 广州医药, 2018, 49(2): 1-5.
[13]	刘俊, 李荣华. 稳定期COPD患者血清suPAR、IL-8、MMP-9的水平及其意义[J]. 广州医药, 2018, 49(2): 50-53.
[14]	萧鲲, 林虹, 杨婉瑜, 朱丽娟, 许浦生. 载脂蛋白E基因多态性在慢性阻塞性肺疾病合并阿尔茨海默病患者中的分布和意义[J]. 广州医药, 2018, 49(2): 84-90.
[15]	侯达繁, 黄方, 于世平, 谭永清, 骆嘉杰, 袁清妹. 八段锦联合呼吸训练对社区慢性阻塞性肺疾病患者疗效研究[J]. 广州医药, 2017, 48(6): 29-32.